30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Henrik Stage

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return 657%
Success rate 73%
Average holding period 220
Transactions 28
Henrik Stage's trades of SynAct Pharma AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-03-01 2021-02-26 S Sale
29,774
137.59
SEK4,686,177
29,774 137.59 SEK4,686,177
2021-03-01 2021-02-25 S Sale
3,064
421.23
SEK417,050
3,064 421.23 SEK417,050
2021-03-01 2021-02-24 S Sale
7,364
40.05
SEK4,833,150
7,364 40.05 SEK4,833,150
2020-03-17 2019-12-02 B Purchase
7,460
24.80
SEK185,008
7,460 24.80 SEK185,008
2019-07-11 2019-06-19
SE RhoVac AB (RHOVAC)
B Purchase
5,556
19.00
SEK105,564
5,556 19.00 SEK105,564
2018-05-09 2018-05-03 B Purchase
20,202
9.90
SEK200,000
20,202 9.90 SEK200,000
2017-10-06 2017-10-03 B Purchase
7,000
6.89
SEK48,264
7,000 6.89 SEK48,264